| Not Yet Recruiting | ScvO2-Centered Optimisation of RED Blood Cell Transfusions NCT07509203 | Semmelweis University | N/A |
| Not Yet Recruiting | A Study to Evaluate Efficacy and Safety of QLG1218(Daprodustat) in Chinese Hemodialysis (HD)-Dependent Subject NCT07300111 | Qilu Pharmaceutical Co., Ltd. | Phase 3 |
| Not Yet Recruiting | Probiotics Against Erythropoietin Resistance in Chronic Kidney Disease Patients. NCT07296146 | Badr University | Phase 3 |
| Recruiting | The Effect of an Oral Nutritional Supplement on the Nutritional and Health Outcomes of the Elderly NCT06773975 | University of Ghana | Phase 1 |
| Recruiting | Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study NCT06884280 | Hull University Teaching Hospitals NHS Trust | Phase 3 |
| Not Yet Recruiting | the MCCE vs EGD Trial NCT07004530 | Chinese University of Hong Kong | N/A |
| Recruiting | Robot-assisted Cystectomies With Regard to Blood Loss, Pain and Transfusions. NCT07008261 | Goethe University | — |
| Completed | Transfusion Practices in Intensive Care Units: a Hungarian Nationwide Survey NCT07532772 | Pest County Flór Ferenc Hospital | — |
| Not Yet Recruiting | Study on Effect of Papworth Technique in Anemic Asthmatic Pediatrics NCT06750354 | Cairo University | N/A |
| Completed | Burden of Schistosomiasis and Soil-transmitted Helminth Infections in Schoolchildren in Banfora, Burkina Faso NCT06973200 | Centre MURAZ/Institut National de Santé Publique | — |
| Completed | Bioequivalence Study of Ferric Carboxymaltose Injection in Participants With Iron Deficiency Anaemia NCT06080555 | Sichuan Huiyu Pharmaceutical Co., Ltd | Phase 1 |
| Completed | Anemia Studies in CKD: Erythropoiesis Via a Novel PHI Daprodustat - Pediatric (ASCEND-P) NCT05682326 | GlaxoSmithKline | Phase 3 |
| Completed | South African Paediatric Surgical Outcomes Study 2 NCT05681871 | University of Cape Town | Phase 4 |
| Completed | Comparison of Daprodustat Formulations Produced by Two Methods of Manufacture for Bioequivalence and Dissoluti NCT04640311 | GlaxoSmithKline | Phase 1 |
| Completed | Anemia Studies in CKD: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat- Iron (ASCEND NCT03457701 | GlaxoSmithKline | Phase 2 |
| Completed | Efficacy of Three Novel Bi-treated Long Lasting Insecticidal Nets NCT03554616 | London School of Hygiene and Tropical Medicine | N/A |
| Terminated | Anemia Study in Chronic Kidney Disease (CKD) : Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) D NCT03446612 | GlaxoSmithKline | Phase 2 |
| Completed | Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) NCT03400033 | GlaxoSmithKline | Phase 3 |
| Completed | Daprodustat Bioequivalence and Food Effect Study NCT03493386 | GlaxoSmithKline | Phase 1 |
| Withdrawn | Safety and Efficacy Study of a Food Supplement for Pregnant and Lactating Women NCT02190565 | Oriflame Cosmetics AB | N/A |
| Completed | Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) NCT03409107 | GlaxoSmithKline | Phase 3 |
| Completed | Absorption and Elimination of Radiolabeled Daprodustat NCT03239522 | GlaxoSmithKline | Phase 1 |
| Completed | Anemia Study in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Da NCT03029247 | GlaxoSmithKline | Phase 2 |
| Completed | Daprodustat Hepatic Impairment Study NCT03223337 | GlaxoSmithKline | Phase 1 |
| Completed | Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) NCT03029208 | GlaxoSmithKline | Phase 3 |
| Completed | A Study to Evaluate Efficacy and Safety of Daprodustat Compared to Darbepoetin Alfa in Japanese Hemodialysis ( NCT02969655 | GlaxoSmithKline | Phase 3 |
| Completed | Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat- NCT02879305 | GlaxoSmithKline | Phase 3 |
| Completed | Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat- NCT02876835 | GlaxoSmithKline | Phase 3 |
| Terminated | Evaluation of Accuracy and Precision of a New Arterial Blood Gas Analysis System Blood in Comparison With the NCT02801162 | Universitair Ziekenhuis Brussel | N/A |
| Completed | Efficacy and Safety Study of GSK1278863 in Japanese Hemodialysis Subjects With Anemia Associated With Chronic NCT02829320 | GlaxoSmithKline | Phase 3 |
| Completed | Intravenous Iron for Treatment of Anaemia Before Cardiac Surgery NCT02632760 | Bayside Health | Phase 4 |
| Completed | Phase III Study of GSK1278863 in Japanese Non-dialysis (ND) and Peritoneal Dialysis (PD) Subjects With Renal A NCT02791763 | GlaxoSmithKline | Phase 3 |
| Completed | Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Three-times Weekly Dosing of GSK1278863 in Hemo NCT02689206 | GlaxoSmithKline | Phase 2 |
| Withdrawn | Prednisone Plus Chloroquine for the Treatment of Hyper-reactive Malarial Splenomegaly NCT01785979 | Lihir Medical Centre | Phase 3 |
| Completed | The UK CAVIAR Study NCT02637102 | University College, London | — |
| Completed | Treatment Response in Dialysis Anaemia NCT02707757 | Imperial College Healthcare NHS Trust | Phase 4 |
| Completed | Long Term Effect of Early Iron Supplementation and Psychosocial Stimulation on Growth and Development of Iron- NCT02801721 | International Centre for Diarrhoeal Disease Research, Bangladesh | N/A |
| Completed | Drug-drug Interaction Study of GSK1278863 With Pioglitazone, Rosuvastatin and Trimethoprim in Healthy Adult Vo NCT02371603 | GlaxoSmithKline | Phase 1 |
| Unknown | Effectiveness of a Biosimilar Epoetin Alfa in Stable 'End Stage Renal Failure' NCT02341547 | Penang Hospital, Malaysia | — |
| Completed | Single Dose, Pharmacokinetic, Safety, Tolerability and QTc Study of GSK1278863 in Healthy Volunteers NCT02293148 | GlaxoSmithKline | Phase 1 |
| Completed | Study to Assess the Pharmacokinetics of GSK1278863 in Subjects With End Stage Renal Disease Undergoing Periton NCT02243306 | GlaxoSmithKline | Phase 1 |
| Completed | Evaluation of a Novel Long Lasting Insecticidal Net and Indoor Residual Spray Product NCT02288637 | London School of Hygiene and Tropical Medicine | N/A |
| Completed | Study of Haemodialysis Patients Switching From Aranesp to Biosimilar NCT02191150 | Amgen | — |
| Completed | Parenteral Artesunate Compared to Quinine as a Cause of Late Anaemia in African Children With Malaria NCT02092766 | University of Oxford | Phase 4 |
| Completed | Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD NCT02185911 | Amgen | — |
| Completed | Safe and Efficacious Iron for Children in Kenya NCT02073149 | London School of Hygiene and Tropical Medicine | Phase 2 / Phase 3 |
| Completed | Multiple Ascending Dose Study of DS-1093 in Healthy Subjects NCT02142400 | Daiichi Sankyo | Phase 1 |
| Completed | Preoperative Intravenous Iron to Treat Anaemia in Major Surgery NCT01692418 | University College, London | Phase 3 |
| Completed | Study to Evaluate the Safety, Efficacy and Pharmacokinetics of GSK1278863 in Japanese Hemodialysis-Dependent S NCT02019719 | GlaxoSmithKline | Phase 2 |
| Completed | Evaluation of Dose Response Relationship, Safety and Efficacy of GSK1278863 in Hemodialysis-dependent Subjects NCT01977482 | GlaxoSmithKline | Phase 2 |
| Completed | A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Ass NCT01977573 | GlaxoSmithKline | Phase 2 |
| Completed | Impact of Hand Hygiene Activities on the Prevention of Intestinal Parasitic Infections and Anaemia Among Schoo NCT01619254 | Mekelle University | N/A |
| Completed | Seasonal Malaria Chemoprevention Versus Home Management of Malaria in Children Under 5 Years in Ghana NCT01651416 | Centre for Global Health Research, Ghana | Phase 4 |
| Completed | 4 Week Switch Study in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease NCT01587924 | GlaxoSmithKline | Phase 2 |
| Completed | 4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing NCT01587898 | GlaxoSmithKline | Phase 2 |
| Completed | Effects of GSK1278863A on Pulmonary Artery Pressure in Healthy Volunteers NCT01673555 | GlaxoSmithKline | Phase 1 |
| Completed | Iron & Alginate Study NCT01528644 | University of East Anglia | N/A |
| Unknown | Impact of Vitamin B12 Supplementation With Iron and Folic Acid on Adolescent Girls NCT01490944 | Indian Council of Medical Research | Phase 2 |
| Completed | Intermittent Parasite Clearance (IPC) in Schools: Impact on Malaria, Anaemia and Cognition NCT01454752 | London School of Hygiene and Tropical Medicine | N/A |
| Terminated | Assessment of the Pharmacokinetics of GSK1278863 and Metabolites in Normal Subjects and Subjects With Renal Im NCT01406340 | GlaxoSmithKline | Phase 1 |
| Completed | Safety and Efficacy Extension Study of Iron Isomaltoside 1000 (Monofer®) in Subjects With Inflammatory Bowel D NCT01410435 | Pharmacosmos A/S | Phase 3 |
| Completed | Iron Metabolism in Dragon Boat Athletes NCT01431118 | University of Giessen | N/A |
| Completed | Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of GSK1278863A in He NCT02348372 | GlaxoSmithKline | Phase 1 |
| Completed | Switch From Oral Iron to Intravenous Ferric Carboxymaltose in Non-dialysis Chronic Kidney Disease (CKD) NCT02232906 | Hospital Aleman | Phase 4 |
| Completed | Relative Bioavailability Study for GSK1278863A NCT01319006 | GlaxoSmithKline | Phase 1 |
| Completed | Study to Assess the Pharmacokinetics of GSK1278863A Coadministered With a High Fat Meal or an Inhibitor of CYP NCT01376232 | GlaxoSmithKline | Phase 1 |
| Completed | Intermittent Preventive Treatment Versus Scheduled Screening and Treatment of Malaria in Pregnancy NCT01084213 | London School of Hygiene and Tropical Medicine | Phase 4 |
| Unknown | IMPACT2: Monitoring Interventions to Improve Artemisinin-based Combination Therapy (ACT) Access and Targeting NCT01130155 | London School of Hygiene and Tropical Medicine | — |
| Completed | Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficienc NCT01131624 | Vifor Pharma | Phase 3 |
| Terminated | Optimal Transfusion in Anaemic Cancer Patients Treated With Chemotherapy (HaemOPtimal) NCT01116479 | Rigshospitalet, Denmark | Phase 2 |
| Completed | MONITOR-CKD5 - Multi-level Evaluation of Anaemia Treatment, Outcomes, and Determinants in Chronic Kidney Disea NCT01121237 | Sandoz | — |
| Completed | Does Sourdough Fermentation Improve Iron Uptake From Whole Grain Rye Bread? NCT02462798 | Chalmers University of Technology | N/A |
| Completed | Impact of Malaria Prevention on Health and Education in Kenyan Schoolchildren NCT00878007 | London School of Hygiene and Tropical Medicine | N/A |
| Completed | Intermittent Preventive Treatment With Azithromycin-containing Regimens in Pregnant Women in Papua New Guinea NCT01136850 | University of Melbourne | Phase 3 |
| Completed | Study of Erythropoietin (EPO) Administration Schedule NCT01111630 | JW Pharmaceutical | Phase 4 |
| Completed | Nutritional Transition in the Maghreb and Prevention of Obesity and Non-communicable Diseases NCT01844349 | Agnes GARTNER | — |
| Terminated | EFfect of Ferric Carboxymaltose on exercIse CApacity and Cardiac Function in Patients With Iron deficiencY and NCT00821717 | Vifor Pharma | Phase 3 |
| Completed | A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK1278863A in Healt NCT00750256 | GlaxoSmithKline | Phase 1 |
| Completed | Bioequivalence of a Single Subcutaneous Dose of Epoetin Beta in Healthy Japanese and Caucasian Male Subjects NCT01085552 | InCROM Europe Clinical Research | Phase 1 |
| Completed | Different Approaches for Delivery of IPT in Pregnancy in Burkina Faso NCT00494416 | London School of Hygiene and Tropical Medicine | N/A |
| Completed | Oral and Intravenous Iron in Patients Postoperative Cardiovascular Surgery Under Extracorporeal Circulation NCT01078818 | Fundación Canaria Rafael Clavijo para la Investigación Biomédica | Phase 4 |
| Completed | Ferinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF) NCT00520780 | Vifor Pharma | Phase 3 |
| Completed | Intermittent Preventive Treatment (IPTp) Versus Rapid Diagnostic Testing (RDT) and Treatment of Malaria in Pre NCT00432367 | London School of Hygiene and Tropical Medicine | Phase 3 |
| Completed | A Trial of 2 'Point of Care' Diagnostic Methods to Improve Detection and Treatment of Anaemia in African Child NCT00439595 | London School of Hygiene and Tropical Medicine | N/A |
| Completed | Schistosomiasis in Women of Reproductive Age in Burkina Faso: Implications for Control NCT00463632 | DBL -Institute for Health Research and Development | — |
| Completed | Schistosomiasis in Formal and Non-Formal Schools in Uganda: Implications for Control Programmes NCT00463593 | DBL -Institute for Health Research and Development | — |
| Completed | A Placebo-controlled Study to Investigate the Safety, and Pharmacokinetics of Oral GSK626616AC in Healthy Subj NCT00443170 | GlaxoSmithKline | Phase 1 |
| Completed | Schistosome and Intestinal Worm Infections and Malaria Morbidity Among School and Pre-school Children in, Tanz NCT00347113 | DBL -Institute for Health Research and Development | N/A |
| Completed | Assessment of Anaemia Attributable to Schistosomiasis in School Children in Kenya: Mechanisms and Effect of Tr NCT00414479 | DBL -Institute for Health Research and Development | — |
| Completed | Control of Pregnancy Associated Malaria With Intermittent Preventive Treatment NCT00258024 | DBL -Institute for Health Research and Development | N/A |
| Terminated | Acceptability and Cost Effectiveness of Home Based Management of Fever: Different Strategies NCT00259142 | DBL -Institute for Health Research and Development | N/A |
| Completed | Iron Supplementation in Schistosomiasis and Soil Transmitted Helminths Control Programmes in Zambia NCT00276224 | DBL -Institute for Health Research and Development | N/A |
| Unknown | Cohort Study to Determine the Long-Term Safety and Efficacy of Biogeneric Epoetin Treatment for Renal Anemia NCT00238043 | Ministry of Health, Malaysia | Phase 3 |
| Completed | Iron-fortified Whole Maize Flour Trial NCT00386074 | Wageningen University | Phase 2 |
| Completed | Correction of Anaemia and Progression of Renal Failure on Transplanted Patients NCT00396435 | Centre Hospitalier Universitaire, Amiens | Phase 4 |
| Completed | Relationships Between the Use of Antimalarial Drugs in Pregnancy and Plasmodium Falciparum Resistance NCT00140517 | London School of Hygiene and Tropical Medicine | N/A |
| Completed | Intermittent Preventive Treatment for Malaria in Infants in Navrongo Ghana NCT00857077 | London School of Hygiene and Tropical Medicine | N/A |
| Completed | Resistance Exercise Training During Pregnancy: a Randomized Controlled Trial NCT00813657 | Universidad Politecnica de Madrid | Phase 4 |